- Home/
- About MFV/
- Respiratory News/
- Article
2023-24 WHO Influenza Strains and Vaccines
May 16, 2023
The World Health Organization (WHO) has announced its recommendations for the viral composition of influenza vaccines for the 2023-24 flu season in the northern hemisphere.
The WHO recommends that quadrivalent vaccines for use in the 2023-2024 northern hemisphere influenza season contain the following:
Egg-based vaccines
- an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
- an A/Darwin/9/2021 (H3N2)-like virus; and
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
- a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
Cell culture- or recombinant-based vaccines
- an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
- an A/Darwin/6/2021 (H3N2)-like virus;
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
- a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
Prebook your 2023-24 doses now!
MyFluVaccine is now accepting vaccine orders
for the 2023-24 influenza season.
*Please reach out to your Sales Representative for availability.
We appreciate your partnership and thank you for trusting FFF to supply your influenza vaccine needs.
Together, we are Helping Healthcare Care®.